X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (105) 105
humans (99) 99
female (94) 94
oncology (86) 86
middle aged (75) 75
breast neoplasms - pathology (69) 69
adult (62) 62
index medicus (62) 62
aged (61) 61
lymphatic metastasis (57) 57
prognosis (51) 51
breast neoplasms - drug therapy (48) 48
chemotherapy (46) 46
breast neoplasms - mortality (43) 43
cancer (41) 41
node-positive (35) 35
node positive (34) 34
adjuvant chemotherapy (31) 31
care and treatment (31) 31
disease-free survival (30) 30
lymph nodes - pathology (30) 30
surgery (30) 30
chemotherapy, adjuvant (29) 29
neoplasm staging (29) 29
node-positive breast cancer (29) 29
women (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
cyclophosphamide (24) 24
breast neoplasms - surgery (23) 23
survival (23) 23
aged, 80 and over (21) 21
medicine & public health (21) 21
analysis (20) 20
carcinoma (20) 20
follow-up studies (20) 20
survival rate (20) 20
treatment outcome (20) 20
tamoxifen (19) 19
axilla (18) 18
biopsy (18) 18
breast neoplasms - therapy (18) 18
lymphatic system (18) 18
retrospective studies (18) 18
therapy (18) 18
metastasis (17) 17
adjuvant treatment (16) 16
breast neoplasms - metabolism (16) 16
cancer patients (16) 16
cyclophosphamide - administration & dosage (16) 16
lymph nodes (16) 16
risk (16) 16
docetaxel (15) 15
mastectomy (14) 14
metastases (14) 14
breast neoplasms - genetics (13) 13
kaplan-meier estimate (13) 13
paclitaxel (13) 13
patients (13) 13
radiotherapy (13) 13
research (13) 13
sentinel lymph node biopsy (13) 13
survival analysis (13) 13
adjuvant therapy (12) 12
dissection (12) 12
expression (12) 12
fluorouracil (12) 12
hematology, oncology and palliative medicine (12) 12
immunohistochemistry (12) 12
lymph node excision (12) 12
lymphatic metastasis - pathology (12) 12
medical prognosis (12) 12
multivariate analysis (12) 12
neoadjuvant chemotherapy (12) 12
neoplasm recurrence, local (12) 12
abridged index medicus (11) 11
anthracyclines (11) 11
cancer therapies (11) 11
estrogen (11) 11
fluorouracil - administration & dosage (11) 11
neoadjuvant therapy (11) 11
receptors, estrogen - metabolism (11) 11
adjuvant (10) 10
antineoplastic agents - therapeutic use (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
article (10) 10
clinical trials (10) 10
combined modality therapy (10) 10
doxorubicin (10) 10
epirubicin - administration & dosage (10) 10
health aspects (10) 10
patient outcomes (10) 10
proportional hazards models (10) 10
recurrence (10) 10
risk factors (10) 10
lymph node positive (9) 9
management (9) 9
methotrexate (9) 9
pathology (9) 9
randomized-trial (9) 9
recurrence score (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Annals of Surgery, ISSN 0003-4932, 03/2019, Volume 269, Issue 3, pp. 432 - 442
OBJECTIVE:The aim of this study was to perform a systematic review and meta-analysis to assess the accuracy of different surgical axillary staging procedures... 
Neoadjuvant therapy | Usage | Care and treatment | Breast cancer | Diagnosis | Meta-analysis | Meta-Analysis | sentinel lymph node biopsy | iodine seed | breast cancer | node-positive | neoadjuvant systemic therapy | axillary staging
Journal Article
ANNALS OF SURGERY, ISSN 0003-4932, 03/2019, Volume 269, Issue 3, pp. 432 - 442
Objective: The aim of this study was to perform a systematic review and meta-analysis to assess the accuracy of different surgical axillary staging procedures... 
SURGERY | sentinel lymph node biopsy | MULTICENTER | FEASIBILITY | MARKING | LYMPH-NODES | BIOPSY | breast cancer | RADIOACTIVE IODINE SEEDS | neoadjuvant systemic therapy | WIRE LOCALIZATION | PREOPERATIVE CHEMOTHERAPY | iodine seed | CLIPPED NODE | node-positive | axillary staging
Journal Article
Journal Article
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, ISSN 0748-7983, 08/2019
Various options for axillary staging after neoadjuvant systemic therapy (NST) are available for breast cancer patients with a clinically positive axillary node... 
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, Issue 17, pp. 2517 - 2524
Highlights • 82 patients (30%) out of 269 eligible patients accepted to participate. • This is one of the longest follow-up (median 18 years) in breast cancer... 
Hematology, Oncology and Palliative Medicine | Node-positive breast cancer | Adjuvant therapy | Late cardiac toxicity | ADJUVANT CHEMOTHERAPY | HEART-FAILURE | DOXORUBICIN | PREVENTION | CHILDHOOD-CANCER | INDUCED CARDIOTOXICITY | THERAPY | ONCOLOGY | ECHOCARDIOGRAPHY | DYSFUNCTION | SURVIVORS | Outcome Assessment (Health Care) - methods | Cyclophosphamide - administration & dosage | Prognosis | Follow-Up Studies | Humans | Middle Aged | Heart Failure - physiopathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Cyclophosphamide - adverse effects | Ventricular Dysfunction, Left - chemically induced | Dose-Response Relationship, Drug | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Adult | Female | Heart Failure - diagnostic imaging | Echocardiography | Neoplasm Recurrence, Local | Proportional Hazards Models | Survival Rate | Breast Neoplasms - drug therapy | Ventricular Dysfunction, Left - diagnostic imaging | Ventricular Dysfunction, Left - physiopathology | Disease-Free Survival | Methotrexate - adverse effects | Outcome Assessment (Health Care) - statistics & numerical data | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Breast Neoplasms - mortality | Methotrexate - administration & dosage | Heart Failure - chemically induced | Epirubicin - adverse effects
Journal Article
Journal Article
Journal Article
Journal Article
ANNALS OF ONCOLOGY, ISSN 0923-7534, 07/2019, Volume 30, Issue 7, pp. 1044 - 1050
Prediction of benefit from adjuvant chemotherapy following resection of early breast cancer and, as a result, proper selection of candidates remains an elusive... 
adjuvant chemotherapy | PROGNOSIS-SIGNATURE | breast cancer | Oncotype Dx | ESTROGEN-RECEPTOR | 21-GENE RECURRENCE SCORE | DISTANT RECURRENCE | PAM50 RISK | DECISION-MAKING | ONCOLOGY | node-positive | gene expression signature | ADJUVANT SYSTEMIC THERAPY | CLINICAL-PRACTICE | POSTMENOPAUSAL PATIENTS | Reviews
Journal Article